Shiny and New! We Have Launched Our New Website!

dbrock — Tue, 16 Sep 2025 01:29:52 +0000

Shiny and New! We Have Launched Our New Website! dbrock Mon, 09/15/2025 - 18:29

Article and Video CATEGORIES

Cancer Journey

Shiny and New! We Have Launched Our New Website!

dbrock

Mon, 09/15/2025 - 18:29

We are excited to announce our NEW WEBSITE!

Author

Denise Brock

Get Ready to Explore the Refreshed

Global Resource for Advancing Cancer Education Website!

Look at our new look! View a quick video walkthrough below.

GRACE has a fresh new look, and we’re excited to share it with you! What hasn’t changed is everything you count on—reliable, free resources including videos, articles, podcasts, live interactive webinars, and our supportive online community.

Watch the short video below for a quick tour of the updated site and its key features. To explore more about GRACE and see the latest videos, articles, and highlights, you will be able to click the “Learn More” button at the top of our homepage.

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Online Community

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.

Since your doctor didn't seem too worried...

Tell Your Story-Clinical Trials

2025 Blood Cancers OncTalk, Oct 25 10:30 AM (PDT)

Foro en Español Sobre Terapias Dirigidas para el Cáncer de Pulmón

2025 HPV Advances Patient Education Program-Sponsored by Merck

August 9, 2025, Foro de Pacientes sobre Terapias Dirigidas en Cáncer de Pulmón 2025 (Webinar en Vivo)

2024-2025 PEA Program Videos-Thank You Exelixis and Janssen for Your Sponsorship

Recent Comments

JOIN THE CONVERSATION

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome…

By JanineT GRACE … on Mon, 09/22/2025 - 14:30

another question about Tagrisso not working and alternatives

The information you share is…

By LibbieRohan on Sun, 09/21/2025 - 20:55

Pancoast Tumor

Hi Mel, I'm sorry for the…

By JanineT GRACE … on Thu, 08/28/2025 - 11:26

Pancoast Tumor

Hello.
I know this post is…

By mel on Wed, 08/27/2025 - 08:20

2025 Foro de Terapias Dirigidas de Cáncer de Pulmón

AlexandraGBeneke — Mon, 15 Sep 2025 18:33:47 +0000

2025 Foro de Terapias Dirigidas de Cáncer de Pulmón AlexandraGBeneke Mon, 09/15/2025 - 11:33

Article and Video CATEGORIES

Cancer Journey

2025 Foro de Terapias Dirigidas de Cáncer de Pulmón

AlexandraGBeneke

Mon, 09/15/2025 - 11:33

En este evento en directo, virtual, interactivo y dirigido por el Dr. Luis Raez en agosto de 2025, destacados oncólogos se reunieron para debatir las opciones de terapia dirigida en español para pacientes con cáncer de pulmón. El evento incluyó una sesión de preguntas y respuestas para la audiencia.

Author

Luis Raez, MD FACP FCCP

En este video, la Dra. Velázquez Mañana analiza las mutaciones del EGFR, los diferentes subtipos de cáncer de pulmón y cómo determinar cuál es el mejor tratamiento en general.

To watch the complete playlist, click here.

Special thanks to Genentech, BMS, Takeda, Johnson & Johnson, and Daiichi-Sankyo for their sponsorship of this program.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Online Community

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.

Since your doctor didn't seem too worried...

Tell Your Story-Clinical Trials

2025 Blood Cancers OncTalk, Oct 25 10:30 AM (PDT)

Foro en Español Sobre Terapias Dirigidas para el Cáncer de Pulmón

2025 HPV Advances Patient Education Program-Sponsored by Merck

August 9, 2025, Foro de Pacientes sobre Terapias Dirigidas en Cáncer de Pulmón 2025 (Webinar en Vivo)

2024-2025 PEA Program Videos-Thank You Exelixis and Janssen for Your Sponsorship

Recent Comments

JOIN THE CONVERSATION

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome…

By JanineT GRACE … on Mon, 09/22/2025 - 14:30

another question about Tagrisso not working and alternatives

The information you share is…

By LibbieRohan on Sun, 09/21/2025 - 20:55

Pancoast Tumor

Hi Mel, I'm sorry for the…

By JanineT GRACE … on Thu, 08/28/2025 - 11:26

Pancoast Tumor

Hello.
I know this post is…

By mel on Wed, 08/27/2025 - 08:20

Understanding Recurrent and Metastatic HPV-Positive Head and Neck Cancer

AlexandraGBeneke — Mon, 08 Sep 2025 17:44:35 +0000

Understanding Recurrent and Metastatic HPV-Positive Head and Neck Cancer AlexandraGBeneke Mon, 09/08/2025 - 10:44

Article and Video CATEGORIES

Cancer Journey

Understanding Recurrent and Metastatic HPV-Positive Head and Neck Cancer

AlexandraGBeneke

Mon, 09/08/2025 - 10:44

In this series, Dr. Jared Weiss discusses topics in HPV related cancer, including prognosis of advanced disease, the standard of care, and the importance of the HPV vaccination.

Author

GRACE Videos and Articles

What is HPV-positive head and neck cancer?

HPV stands for human papillomavirus, a common virus that can cause certain cancers. When we talk about HPV-positive head and neck cancer, we're referring to cancers that developed because of this viral infection.

In the head and neck region, HPV most commonly affects the oropharynx, which includes the tonsils, base of the tongue, and nearby tissues in the throat. This is different from other head and neck cancers that might be caused by tobacco use or alcohol consumption.

What makes HPV-positive cancers special is that they behave very differently from cancers not caused by HPV. The good news is that HPV-positive cancers usually respond much better to treatment than their HPV-negative counterparts. People diagnosed with HPV-positive head and neck cancer also tend to live longer and have better outcomes overall compared to those with HPV-negative disease. This difference in behavior is so significant that doctors now consider HPV-positive and HPV-negative head and neck cancers to be essentially two different diseases that require different approaches to treatment.

When cancer comes back or spreads

Even though HPV-positive head and neck cancer often responds well to initial treatment, it can sometimes return (recurrent disease) or spread to other parts of the body (metastatic disease).
Most people diagnosed with this type of cancer first receive curative treatment, which might include surgery, radiation therapy, chemotherapy, or a combination of these approaches. The goal of this initial treatment is to completely eliminate the cancer from the body.

However, despite the generally favorable outlook for HPV-positive cancers, some patients will experience cancer recurrence months or years after their initial treatment. When this happens, the cancer might come back in the same area where it originally started, appear in nearby lymph nodes, or spread to distant organs like the lungs, liver, or bones.

If the cancer does return locally or spread after initial treatment, your care team will need to adjust your treatment plan significantly. At this point, the focus shifts to one of two main approaches: either attempting another curative treatment if the recurrence is caught early and in a limited area, or transitioning to treatments aimed at controlling symptoms, slowing the disease's progression, and maintaining your quality of life for as long as possible.

First step: Can it still be cured?

When cancer returns, your care team will first check whether there's still a chance for cure. This is one of the most important evaluations your doctors will perform, as it determines the entire approach to your future treatment.

Surgery may be an option if the cancer has returned to a location that can be operated on safely. Your surgical team will carefully evaluate whether the recurrent tumor can be completely removed without causing unacceptable damage to vital structures or functions like speech and swallowing.
Another possibility is re-irradiation, which means giving radiation therapy again to the area where cancer has returned. Modern radiation techniques allow doctors to deliver precise doses of radiation while carefully limiting damage to healthy tissues that may have been treated before. This approach requires sophisticated planning to balance effectiveness against the risk of complications.

For some patients, targeted local treatments might be appropriate, particularly if the cancer has spread to only a small number of spots. These treatments could include highly focused radiation techniques like stereotactic radiation or surgical removal of individual metastatic sites. This approach, sometimes called treating "oligometastatic" disease, aims to eliminate all visible cancer with localized treatments.

If careful evaluation shows that these curative options aren't possible due to the location, extent, or number of cancer sites, then treatment shifts its focus. In these situations, the goal becomes controlling the cancer's growth, improving symptoms you may be experiencing, and maintaining your quality of life for as long as possible.

Current standard treatments when a cure isn't possible

Immunotherapy has revolutionized how recurrent and metastatic head and neck cancer is treated, offering new hope for patients whose cancer cannot be cured with surgery or radiation alone.

Immunotherapy works by helping your own immune system recognize and attack cancer cells more effectively. Think of it as removing the brakes that cancer uses to hide from your immune system, allowing your body's natural defenses to fight the disease. The most commonly used immunotherapy drug is pembrolizumab, which can be given either alone or in combination with chemotherapy, depending on specific characteristics of your tumor found through laboratory testing.

Whether you receive immunotherapy alone or combined with chemotherapy often depends on the results of a test called PD-L1. PD-L1 is a "marker" or protein found on cancer cells that helps doctors predict how well immunotherapy might work for your particular cancer. If your tumor shows high levels of PD-L1, immunotherapy alone may be sufficient to control your disease effectively. However, if your tumor has lower PD-L1 levels, your oncologist will likely recommend combining immunotherapy with chemotherapy to maximize the treatment's effectiveness.

Other treatment approaches are also available for patients who may not be candidates for immunotherapy or whose disease has progressed despite immunotherapy treatment. Chemotherapy plus cetuximab represents an older standard of care that is still used for some patients who cannot receive immunotherapy due to autoimmune conditions or other medical reasons.

Clinical trials offer access to cutting-edge treatments that may not yet be widely available. These research studies are testing promising new approaches, including therapeutic vaccines specifically designed to train the immune system to target HPV proteins found in your cancer cells. Researchers are also investigating new targeted drugs, including innovative "bispecific" antibodies that can attack cancer cells in multiple ways simultaneously, as well as novel combinations of immunotherapy with other therapies designed to improve treatment results and overcome resistance mechanisms.

Looking to the future

Rates of HPV-related head and neck cancers are rising and may peak in the 2030s. This ongoing increase represents both a significant public health challenge and an area of intense medical focus.

The good news is that prevention through HPV vaccination offers tremendous hope for reducing future cases. As more people receive HPV vaccines, particularly during adolescence before exposure to the virus, we expect to see significant reductions in HPV-related cancers over the coming decades. This means that many future cases of this disease could be prevented entirely, similar to how vaccination programs have reduced other preventable cancers.

At the same time, the current rise in cases has intensified research efforts to develop treatments that are more effective, less toxic, and longer lasting than current options. Scientists and doctors are working to better understand what makes HPV-positive cancers unique so they can design therapies specifically tailored to this disease. This includes developing treatments that target the virus itself, creating more sophisticated immunotherapy approaches, and finding ways to maintain the excellent cure rates we see with initial treatment while reducing the harsh side effects that can impact quality of life.

The research community is also focused on helping the growing number of patients who do experience recurrent or metastatic disease live longer, better lives. This includes not only developing new drugs and treatment combinations but also improving supportive care, managing treatment side effects more effectively, and addressing the unique needs of patients with HPV-positive cancer, who tend to be younger and may face decades of survivorship after treatment.

Questions to ask your doctor

● Is my cancer HPV-positive?

● Could my cancer still be cured?

● What are my treatment options now?

● Am I eligible for a clinical trial?

● What are the side effects of each treatment, and how can they be managed?

● How will treatment affect my daily life?

Key takeaway

HPV-positive head and neck cancer is different from HPV-negative disease — and that’s often a good thing, because it generally responds better to treatment. Even if the cancer comes back or spreads, there are more treatment options today than ever before, including immunotherapy, targeted therapies, and clinical trials.

Knowing your options and asking the right questions can help you and your care team make the best plan for you.

The content of this article has been algorithmically generated by an AI model trained on a wide range of data and is based on a Grace's video transcript from our 2025 HPV Advances Program - https://www.youtube.com/playlist?list=PLWsyUmdjLXhG-0WQu_fdwbhehHJfLKumS Verified by Joseph Steward, Medical Writer.

Every effort has been made to ensure the quality and reliability of the content; however, limitations, inaccuracies, or biases may exist. The content should not be considered a substitute for professional advice, and we recommend seeking professional guidance and independently verifying the information before making decisions based on this content.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Online Community

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.

Since your doctor didn't seem too worried...

Tell Your Story-Clinical Trials

2025 Blood Cancers OncTalk, Oct 25 10:30 AM (PDT)

Foro en Español Sobre Terapias Dirigidas para el Cáncer de Pulmón

2025 HPV Advances Patient Education Program-Sponsored by Merck

August 9, 2025, Foro de Pacientes sobre Terapias Dirigidas en Cáncer de Pulmón 2025 (Webinar en Vivo)

2024-2025 PEA Program Videos-Thank You Exelixis and Janssen for Your Sponsorship

Recent Comments

JOIN THE CONVERSATION

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome…

By JanineT GRACE … on Mon, 09/22/2025 - 14:30

another question about Tagrisso not working and alternatives

The information you share is…

By LibbieRohan on Sun, 09/21/2025 - 20:55

Pancoast Tumor

Hi Mel, I'm sorry for the…

By JanineT GRACE … on Thu, 08/28/2025 - 11:26

Pancoast Tumor

Hello.
I know this post is…

By mel on Wed, 08/27/2025 - 08:20

Clinical Trials Storytelling Program 2024-25

dbrock — Thu, 04 Sep 2025 17:43:15 +0000

Clinical Trials Storytelling Program 2024-25 dbrock Thu, 09/04/2025 - 10:43

Article and Video CATEGORIES

Cancer Journey

Clinical Trials Storytelling Program 2024-25

dbrock

Thu, 09/04/2025 - 10:43

GRACE's 2024-2025 Clinical Trials Experiences Through Storytelling Program - Patient Perspectives on the Clinical Trials process.

Author

Denise Brock

In this series, the 2024-25 Clinical Trials Experiences Through Storytelling Program, we talk to cancer survivors who have a passion for telling their stories in order to help others who may be navigating the clinical trials experience.

In this first series of videos, Catherine Wambugu, who lives in Nairobi, Kenya, takes us through the story of her diagnosis of ALL and the lack of knowledge she had as a young person being handed this diagnosis. She speaks of the lack of medical care available in her country, and the eventual clinical trial she was able to access, which ultimately saved her life. Thank you to our Sponsors! #lilly #exelixis

To join the conversation or ask a question, visit https://cancergrace.org/forum.

To see the full playlist on YouTube, please click this link.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Online Community

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.

Since your doctor didn't seem too worried...

Tell Your Story-Clinical Trials

2025 Blood Cancers OncTalk, Oct 25 10:30 AM (PDT)

Foro en Español Sobre Terapias Dirigidas para el Cáncer de Pulmón

2025 HPV Advances Patient Education Program-Sponsored by Merck

August 9, 2025, Foro de Pacientes sobre Terapias Dirigidas en Cáncer de Pulmón 2025 (Webinar en Vivo)

2024-2025 PEA Program Videos-Thank You Exelixis and Janssen for Your Sponsorship

Recent Comments

JOIN THE CONVERSATION

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome…

By JanineT GRACE … on Mon, 09/22/2025 - 14:30

another question about Tagrisso not working and alternatives

The information you share is…

By LibbieRohan on Sun, 09/21/2025 - 20:55

Pancoast Tumor

Hi Mel, I'm sorry for the…

By JanineT GRACE … on Thu, 08/28/2025 - 11:26

Pancoast Tumor

Hello.
I know this post is…

By mel on Wed, 08/27/2025 - 08:20

Be a Part of the Patient Perspectives: Clinical Trials Storytelling Program - 2025-26

dbrock — Thu, 21 Aug 2025 19:03:37 +0000

Be a Part of the Patient Perspectives: Clinical Trials Storytelling Program - 2025-26 dbrock Thu, 08/21/2025 - 12:03

Article and Video CATEGORIES

Cancer Journey

Be a Part of the Patient Perspectives: Clinical Trials Storytelling Program - 2025-26

dbrock

Thu, 08/21/2025 - 12:03

Patient Perspectives: Clinical Trials Experiences - Storytelling Program - 2025-26

Author

Denise Brock

Clinical Trials Storytelling Application - Downloadable Document

Tell your story and help us help others!

GRACE Patient Perspectives: Clinical Trials Storytelling Program - 2025-26 - Overview

Apply online here

The goal of this Patient Perspectives program is to give a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. By telling your story, you can educate others on the process, discuss your difficulties, and share your accomplishments. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. This is a paid opportunity, and you will receive a stipend for your participation!

Storytelling will take the form of written, video, and/or audio/podcast to reach the largest audience. GRACE staff will coach and support participants on digital outreach and advocacy.

All people currently enrolled in, or with past enrollment in, a clinical trial for a cancer diagnosis are welcome and encouraged to apply. GRACE’s designated committee will review the nominees and select up to 3 applicants for participation in the 2025-26 program.

Who is GRACE?

The Global Resource for Advancing Cancer Education (GRACE, cancerGRACE.org) is a non-profit organization founded by leading Thoracic Oncologist, Dr. Howard (Jack) West, in 2007. GRACE’s mission is to provide expert-mediated information directly to people with a cancer diagnosis and their caregivers to empower them to become direct partners in their cancer treatment. We currently produce over 300 short videos each year, reaching our community in over 190 countries.

Benefits of Participation

Applicants selected for this year’s program will work closely with GRACE staff to develop new educational content and learn new communication skills through the storytelling process.
Participants will receive training on digitally distributed content, social media, and other platforms. Participants' work will be highlighted and shared by GRACE, our network of established leaders in the oncology community, and GRACE board members with an array of interests and connections.

Participants will receive a stipend, and training in communication and media platforms.

Expectations

Participants will work with GRACE to develop program formats and production, and will present a proposal based on their experience in a clinical trial program. Participants will be expected to attend (via ZOOM) regular meetings throughout the program year to learn and to discuss their ideas. A minimum of three (3) media productions per participant will be expected by the end of the program.

Ideal Candidate

People who are navigating a cancer diagnosis, who are currently or have been involved in a clinical trial, and who have a passion for helping others and telling their stories are ideal for this program.

Applicants should have a particular interest and passion for communications, sharing experiences, storytelling, and patient education. People looking for a way to give back to the cancer community, who exhibit strong written and oral communication skills coupled with a passion for sharing experiences to educate and advocate, will thrive in this program. GRACE will guide them through boosting their voice to advocate for themselves and others in the cancer community.

2025 is our fifth year for this program, and we are excited to continue to generate a platform for patient advocacy and sharing patient education in the area of clinical trials.

The application due date is October 5, 2025. Applicants will be contacted by October 25, 2025, with information regarding acceptance and the next steps.

To apply online, please click here, OR download the above-attached PDF form and email it to dbrock@cancerGRACE.org.

Any questions, please contact Denise Brock at dbrock@cancergrace.org or 888-501-1025 x2.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Online Community

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.

Since your doctor didn't seem too worried...

Tell Your Story-Clinical Trials

2025 Blood Cancers OncTalk, Oct 25 10:30 AM (PDT)

Foro en Español Sobre Terapias Dirigidas para el Cáncer de Pulmón

2025 HPV Advances Patient Education Program-Sponsored by Merck

August 9, 2025, Foro de Pacientes sobre Terapias Dirigidas en Cáncer de Pulmón 2025 (Webinar en Vivo)

2024-2025 PEA Program Videos-Thank You Exelixis and Janssen for Your Sponsorship

Recent Comments

JOIN THE CONVERSATION

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome…

By JanineT GRACE … on Mon, 09/22/2025 - 14:30

another question about Tagrisso not working and alternatives

The information you share is…

By LibbieRohan on Sun, 09/21/2025 - 20:55

Pancoast Tumor

Hi Mel, I'm sorry for the…

By JanineT GRACE … on Thu, 08/28/2025 - 11:26

Pancoast Tumor

Hello.
I know this post is…

By mel on Wed, 08/27/2025 - 08:20

Bajo demanda - Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025

dbrock — Fri, 15 Aug 2025 18:32:22 +0000

Bajo demanda - Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 dbrock Fri, 08/15/2025 - 11:32

Article and Video CATEGORIES

Cancer Journey

Bajo demanda - Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025

dbrock

Fri, 08/15/2025 - 11:32

Vea el seminario web ahora ONDEMAND

Author

Luis Raez, MD FACP FCCP

The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended.

¡Los vídeos están disponibles BAJO DEMANDA!

Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas.

Este evento educativo para pacientes, en directo, virtual e interactivo, incluye presentaciones y mesas redondas que cubren temas generales relevantes para una amplia gama de cánceres de pulmón y opciones de tratamiento, así como la oportunidad de hablar con los expertos en una sesión de preguntas y respuestas. Entre los ponentes se incluyen profesionales médicos de primera línea que presentarán debates centrados en el paciente para educar a las comunidades de pacientes y cuidadores.

El vídeo completo está disponible en nuestro canal de YouTube a través de este enlace: https://youtu.be/weVgK25pmOk?si=Be5kWvaZ2OgZrIJR

Todas las diapositivas disponibles se encuentran en «Documentos disponibles para descargar» en la barra lateral izquierda de la plataforma del evento.

https://live.classy.org/attend/2025-spanish-lung-cancer-targeted-therapies-patient-forum/cbb3cf12-d35b-48ab-bc36-e017862b9ec5/content

Muchas gracias a nuestros patrocinadores por este evento! #janssen #takeda #genentech #bms #daiichisankyo

Si tiene más preguntas, visite nuestros foros de discusión en https://cancergrace.org/forum.

Thank you again for joining us!

Video Language

Spanish

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Online Community

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.

Since your doctor didn't seem too worried...

Tell Your Story-Clinical Trials

2025 Blood Cancers OncTalk, Oct 25 10:30 AM (PDT)

Foro en Español Sobre Terapias Dirigidas para el Cáncer de Pulmón

2025 HPV Advances Patient Education Program-Sponsored by Merck

August 9, 2025, Foro de Pacientes sobre Terapias Dirigidas en Cáncer de Pulmón 2025 (Webinar en Vivo)

2024-2025 PEA Program Videos-Thank You Exelixis and Janssen for Your Sponsorship

Recent Comments

JOIN THE CONVERSATION

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome…

By JanineT GRACE … on Mon, 09/22/2025 - 14:30

another question about Tagrisso not working and alternatives

The information you share is…

By LibbieRohan on Sun, 09/21/2025 - 20:55

Pancoast Tumor

Hi Mel, I'm sorry for the…

By JanineT GRACE … on Thu, 08/28/2025 - 11:26

Pancoast Tumor

Hello.
I know this post is…

By mel on Wed, 08/27/2025 - 08:20

2025 HPV Advances Program

AlexandraGBeneke — Wed, 13 Aug 2025 14:13:26 +0000

2025 HPV Advances Program AlexandraGBeneke Wed, 08/13/2025 - 07:13

Article and Video CATEGORIES

Cancer Journey

2025 HPV Advances Program

AlexandraGBeneke

Wed, 08/13/2025 - 07:13

In this series, Dr. Jared Weiss discusses topics in HPV related cancer, including prognosis of advanced disease, the standard of care, and the importance of the HPV vaccination.

Author

Jared Weiss, MD

In these videos, Dr. Jared Weiss provides a brief overview of the HPV vaccination and its role in head and neck cancer, examines cetuximab as the prior standard of care for patients with head and neck cancer, discusses the current standard of care for these patients, and discusses the prognosis of patients with advanced HPV+ head and neck cancer.

To watch the complete playlist, click here.

Special thanks to Merck for its sponsorship of this program.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Online Community

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.

Since your doctor didn't seem too worried...

Tell Your Story-Clinical Trials

2025 Blood Cancers OncTalk, Oct 25 10:30 AM (PDT)

Foro en Español Sobre Terapias Dirigidas para el Cáncer de Pulmón

2025 HPV Advances Patient Education Program-Sponsored by Merck

August 9, 2025, Foro de Pacientes sobre Terapias Dirigidas en Cáncer de Pulmón 2025 (Webinar en Vivo)

2024-2025 PEA Program Videos-Thank You Exelixis and Janssen for Your Sponsorship

Recent Comments

JOIN THE CONVERSATION

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome…

By JanineT GRACE … on Mon, 09/22/2025 - 14:30

another question about Tagrisso not working and alternatives

The information you share is…

By LibbieRohan on Sun, 09/21/2025 - 20:55

Pancoast Tumor

Hi Mel, I'm sorry for the…

By JanineT GRACE … on Thu, 08/28/2025 - 11:26

Pancoast Tumor

Hello.
I know this post is…

By mel on Wed, 08/27/2025 - 08:20

Patient Education Ambassadors Program 2024-25

AlexandraGBeneke — Tue, 12 Aug 2025 20:41:17 +0000

Patient Education Ambassadors Program 2024-25 AlexandraGBeneke Tue, 08/12/2025 - 13:41

Article and Video CATEGORIES

Cancer Journey

Patient Education Ambassadors Program 2024-25

AlexandraGBeneke

Tue, 08/12/2025 - 13:41

GRACE's 2024-2025 Patient Education Ambassadors discuss topics in cancer, including leukemia, antibody drug conjugates, and more, in both English and Spanish.

Author

GRACE Videos and Articles

In this Program, Drs. Arya Mariam Roy, Assistant Professor at The Ohio State University, Erick Saldanha, Medical Oncologist & Postdoctoral Clinical Fellow at Princess Margaret Cancer Centre, Guilherme Sacchi de Camargo Correia, Hematology and Oncology fellow at Mayo Clinic in Jacksonville, Florida, Maria Velez Velez, Hematology-Oncology fellow at the University of California, Los Angeles, and Marie Dreyer, second-year hematology/oncology fellow at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, Illinois, discuss topics in cancer, including leukemia, antibody drug conjugates, and more.

To watch the complete playlist, click here.

Special thanks to Janssen and Exelixis for sponsoring this program.

Video Language

Spanish

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Online Community

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.

Since your doctor didn't seem too worried...

Tell Your Story-Clinical Trials

2025 Blood Cancers OncTalk, Oct 25 10:30 AM (PDT)

Foro en Español Sobre Terapias Dirigidas para el Cáncer de Pulmón

2025 HPV Advances Patient Education Program-Sponsored by Merck

August 9, 2025, Foro de Pacientes sobre Terapias Dirigidas en Cáncer de Pulmón 2025 (Webinar en Vivo)

2024-2025 PEA Program Videos-Thank You Exelixis and Janssen for Your Sponsorship

Recent Comments

JOIN THE CONVERSATION

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome…

By JanineT GRACE … on Mon, 09/22/2025 - 14:30

another question about Tagrisso not working and alternatives

The information you share is…

By LibbieRohan on Sun, 09/21/2025 - 20:55

Pancoast Tumor

Hi Mel, I'm sorry for the…

By JanineT GRACE … on Thu, 08/28/2025 - 11:26

Pancoast Tumor

Hello.
I know this post is…

By mel on Wed, 08/27/2025 - 08:20

2025 Genitourinary Cancers Patient Education Library

AlexandraGBeneke — Sat, 09 Aug 2025 03:04:53 +0000

2025 Genitourinary Cancers Patient Education Library AlexandraGBeneke Fri, 08/08/2025 - 20:04

Article and Video CATEGORIES

Cancer Journey

2025 Genitourinary Cancers Patient Education Library

AlexandraGBeneke

Fri, 08/08/2025 - 20:04

Dr. Matthew Kurian and Dr. Karine Tawagi discuss topics in GU cancers, including kidney and bladder.

Author

Alexandra Guandique-Beneke

In this series, Dr. Matthew Kurian, Staff Oncologist at St. Elizabeth Healthcare, and Dr. Karine Tawagi, Division of Hematology & Oncology at UI Health, discuss topics related to GU cancers, including kidney and bladder cancers.

To watch the complete playlist, click here.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Online Community

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.

Since your doctor didn't seem too worried...

Tell Your Story-Clinical Trials

2025 Blood Cancers OncTalk, Oct 25 10:30 AM (PDT)

Foro en Español Sobre Terapias Dirigidas para el Cáncer de Pulmón

2025 HPV Advances Patient Education Program-Sponsored by Merck

August 9, 2025, Foro de Pacientes sobre Terapias Dirigidas en Cáncer de Pulmón 2025 (Webinar en Vivo)

2024-2025 PEA Program Videos-Thank You Exelixis and Janssen for Your Sponsorship

Recent Comments

JOIN THE CONVERSATION

Can lung cancer be asymptomatic?

Hello Natalieaster, Welcome…

By JanineT GRACE … on Mon, 09/22/2025 - 14:30

another question about Tagrisso not working and alternatives

The information you share is…

By LibbieRohan on Sun, 09/21/2025 - 20:55

Pancoast Tumor

Hi Mel, I'm sorry for the…

By JanineT GRACE … on Thu, 08/28/2025 - 11:26

Pancoast Tumor

Hello.
I know this post is…

By mel on Wed, 08/27/2025 - 08:20

Featured Content

Shiny and New! We Have Launched Our New Website!

Article and Video CATEGORIES

Cancer Journey

Search By

Get Ready to Explore the Refreshed

Global Resource for Advancing Cancer Education Website!

Look at our new look! View a quick video walkthrough below.

Online Community

Recent Comments

2025 Foro de Terapias Dirigidas de Cáncer de Pulmón

Article and Video CATEGORIES

Cancer Journey

Search By

Online Community

Recent Comments

Understanding Recurrent and Metastatic HPV-Positive Head and Neck Cancer

Article and Video CATEGORIES

Cancer Journey

Search By

What is HPV-positive head and neck cancer?

When cancer comes back or spreads

First step: Can it still be cured?

Current standard treatments when a cure isn't possible

Looking to the future

Questions to ask your doctor

Key takeaway

Online Community

Recent Comments

Clinical Trials Storytelling Program 2024-25

Article and Video CATEGORIES

Cancer Journey

Search By

Online Community

Recent Comments

Be a Part of the Patient Perspectives: Clinical Trials Storytelling Program - 2025-26

Article and Video CATEGORIES

Cancer Journey

Search By

Tell your story and help us help others!

Online Community

Recent Comments

Bajo demanda - Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025

Article and Video CATEGORIES

Cancer Journey

Search By

The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended.

¡Los vídeos están disponibles BAJO DEMANDA!

Muchas gracias a nuestros patrocinadores por este evento! #janssen #takeda #genentech #bms #daiichisankyo

Thank you again for joining us!

Online Community

Recent Comments

2025 HPV Advances Program

Article and Video CATEGORIES

Cancer Journey

Search By

Online Community

Recent Comments

Patient Education Ambassadors Program 2024-25

Article and Video CATEGORIES

Cancer Journey

Search By

Online Community

Recent Comments

2025 Genitourinary Cancers Patient Education Library

Article and Video CATEGORIES

Cancer Journey

Search By

Online Community

Recent Comments